Driven by that ethos for over sixty years, Waters has continually pioneered chromatography, mass spectrometry and thermal analysis innovations. Whether it’s discovering new pharmaceuticals, assuring the safety of the world’s food and water supplies, or ensuring the integrity of a chemical entity in production, we are constantly working with our 40,000+ customers to change the world.

GBC designs, manufactures and markets a range of scientific instruments. GBC is a major manufacturer of analytical instruments including Absorption Spectrometer (AAS), Inductively Coupled Plasma Optical Emission Spectrometer (ICP-OES), UV-Visible Spectrophotometers (UV-Vis), Inductively Coupled Plasma Time-of-Flight Mass Spectrometer (ICP-oTOFMS), High Performance Liquid Chromatography (HPLC) and X-ray Diffractometer (XRD).

LabGenomics is a healthcare company specialized on molecular diagnostics grown up in the market thru development of new effective diagnostic methods related various kinds of diseases. Starting 2002, our company has concentrated on molecular diagnostic market and has developed a lot of tools of genetic analysis using the state of the art technology. Securing more than 3.000 hospitals and clinics including 200 maternity clinics as our clients making use of 20 sales branches covering entire market of Korea is one of strong points we possesses.
From 2007. using analysis technology, knowhow and clinical data accumulated, we started to enlarge our business portfolio to manufacturing diagnostic products like DNA chip, PCR kits, POCT as well as medical devices after struggling to invest our considerable resources in R&D and implemented succeful items in the market. Recently LabGenomics has diversified our business to NGS based diagnostics not only in sequencing service. Main services shall be NIPT (Non Invasive Parental Test), Cancer panel, Predisposition panel and PGS as a result of investing in NGS technology and Bioinformatics. We are going to do our best to proivide higher quality of helthcare services to the public realizing personalized medicine and preventive medicine thru early detection of diseases.

Established in 2006, Genolution Inc. has been providing solutions toward a better life by focusing on the fields of molecular diagnostics and RNAi. Our core technologies to develop faster, more affordable, and higher through-put nucleic acid extraction platforms led to the development of the Nextractor® nucleic acid extraction instrument series and extraction kits; they were vital for our progress in the fields of molecular diagnostics, genetic testing, and life sciences research. Moreover, our double-stranded RNA (dsRNA) synthesis technology enabled us to equip researchers with large-scale dsRNA for gene expression studies and pest control product development.